Literature DB >> 26940742

Pyrithione Zn selectively inhibits hypoxia-inducible factor prolyl hydroxylase PHD3.

Yu-Ran Na1, Dustin J Woo2, So Yeon Kim3, Eun Gyeong Yang4.   

Abstract

Increasing evidence emphasizes the role of the hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) isoforms in regulating non-HIF substrates, but isoform selective PHD inhibitors under physiological conditions have not yet been reported. Here we have identified pyrithione Zn (PZ) as a potent, isoform-selective PHD3 inhibitor. The IC50 value of PZ was determined as 0.98 μM for PHD3, while it did not show any inhibitory activity toward full length and truncated PHD2 up to 1 mM. The selective efficacy of PZ was further demonstrated at the cellular level by observing inhibition of the PHD3-dependent DNA damage response pathway without stabilization of HIF-1α.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypoxia-inducible factor; Isoform selective inhibitor; Prolyl hydroxylase; Pyrithione Zn

Mesh:

Substances:

Year:  2016        PMID: 26940742     DOI: 10.1016/j.bbrc.2016.02.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Downregulation of Proline Hydroxylase 2 and Upregulation of Hypoxia-Inducible Factor 1α are Associated with Endometrial Cancer Aggressiveness.

Authors:  Chengcheng Zhu; Huafeng Ding; Junwen Yang; Yihui Zhou; Yonghong Luo; Suhua Shi; Ying Zhang; Yalan Wei; Guantai Ni
Journal:  Cancer Manag Res       Date:  2019-11-22       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.